Assessment of the Quality of Injectable Antibiotics in Benin
- PMID: 35895356
- PMCID: PMC9294693
- DOI: 10.4269/ajtmh.21-0844
Assessment of the Quality of Injectable Antibiotics in Benin
Abstract
Substandard and falsified medicines are an enormous threat to global health. Poor quality antibiotic preparations contribute to the development of antimicrobial resistance. In surgery, where the occurrence of healthcare-associated infections is high, healthcare teams need to rely on the quality of antibiotic prophylaxis to prevent infections. We assessed the quality of antibiotics used for surgical infection prophylaxis in Benin. Thirty-three samples were collected from six hospitals located in various departments in Benin. The antibiotics (powders for injection: amoxicillin + clavulanic acid, ampicillin, ceftriaxone; solutions for injection: ciprofloxacin, gentamicin, metronidazole) were assessed using visual inspection, pharmacotechnical tests (including uniformity of mass, pH measure, sterility test, and active pharmaceutical ingredient identification), and assay tests (including a simple analytical method thin layer chromatography) and complex analytical techniques (ultraviolet-visible spectrophotometry, high-performance liquid chromatography-diode-array detection, conductometry). Because the material needed for the methods recommended by the pharmacopeias to assess the dosage of gentamicin was not available, we developed and validated a conductometry method. Results showed that 97% (n = 32) of the samples passed visual inspection; 100% (n = 33) of the samples passed the pharmacotechnical tests, identification of active ingredients, and sterility test; 88% (n = 29) passed the test for percentage of active pharmaceutical ingredients. Overall, 15% of the samples did not pass the quality test (3% on visual inspection and 12% for excess active ingredients). Although most of the samples passed the quality tests, it appears important to perform routine quality control for intravenous medicines.
Figures



Similar articles
-
Detection of Poor Quality Artemisinin-based Combination Therapy (ACT) Medicines Marketed in Benin Using Simple and Advanced Analytical Techniques.Curr Drug Saf. 2017;12(3):178-186. doi: 10.2174/1574886312666170616092457. Curr Drug Saf. 2017. PMID: 28625144
-
Burden of and factors associated with poor quality antibiotic, antimalarial, antihypertensive and antidiabetic medicines in Malawi.PLoS One. 2022 Dec 27;17(12):e0279637. doi: 10.1371/journal.pone.0279637. eCollection 2022. PLoS One. 2022. PMID: 36574444 Free PMC article.
-
A random survey of the prevalence of falsified and substandard antibiotics in the Lao PDR.J Antimicrob Chemother. 2019 Aug 1;74(8):2417-2425. doi: 10.1093/jac/dkz164. J Antimicrob Chemother. 2019. PMID: 31049576 Free PMC article.
-
Community-based antibiotic delivery for possible serious bacterial infections in neonates in low- and middle-income countries.Cochrane Database Syst Rev. 2019 Apr 11;4(4):CD007646. doi: 10.1002/14651858.CD007646.pub3. Cochrane Database Syst Rev. 2019. PMID: 30970390 Free PMC article.
-
Characterizing Medicine Quality by Active Pharmaceutical Ingredient Levels: A Systematic Review and Meta-Analysis across Low- and Middle-Income Countries.Am J Trop Med Hyg. 2022 Jun 15;106(6):1778-1790. doi: 10.4269/ajtmh.21-1123. Print 2022 Jun 15. Am J Trop Med Hyg. 2022. PMID: 35895431 Free PMC article.
References
-
- WHO , 2011. The World Medicines Situation 2011. Medicines Prices, Availability and Affordability. Geneva, Switzerland: World Health Organization. Available at: https://www.who.int/medicines/areas/policy/world_medicines_situation/WMS....
-
- WHO , 2017. Global Surveillance and Monitoring System for Substandard and Falsifed Medical Products. Geneva, Switzerland: World Health Organization. Available at: https://www.who.int/publications/i/item/WHO-MVP-EMP-SAV-2019.04.
-
- Delepierre A, Gayot A, Carpentier A, 2012. Update on counterfeit antibiotics worldwide; public health risks. Med Mal Infect 42: 247–255. - PubMed
-
- Ebrahim GJ, 1993. The Bamako initiative. J Trop Pediatr 39: 66–67. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases